Clinical Trials Directory

Trials / Completed

CompletedNCT01735487

CogEcig: Cognitive Functioning and Electronic Cigarette

Electronic Cigarette and Cognitive Functioning: (CogEcig)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Universita degli Studi di Catania · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of the present study is to compare cognitive scores (attention, executive function and working memory) of different e-Cigarette strength with usual cigarettes.

Detailed description

The study is randomised cross-over trial designed to compare: 1) Cognitive performances levels for four different e-Cigarette strength. Participants will be requested to abstain from smoking and alcohol from 20:00 on the night before each study day and from food and caffeine for at least 1 h before the session. On arrival at the study centre, carbon monoxide (CO) will be measured in participants' expired breath. If CO will be \>15 parts per million (ppm), the assigned study treatment will be allocated; however, if CO was \>15 ppm or they will report smoking in the previous 12 h, participants will be rescheduled wherever possible to a subsequent session. On the first study day, participants will be randomised to use one of five ordered conditions: Electronic Nicotine Delivery Device (ENDD) (fourth generation) containing nicotine 2,4%; Electronic Nicotine Delivery Device (ENDD (second generation) containing nicotine 7,4 mg; Electronic Nicotine Delivery Device (ENDD containing nicotine 9 mg; Electronic Nicotine Delivery Device (ENDD nicotine free; their usual cigarette. Additionally participants will be trained to use an electronic cigarette. The following tests will be completed at the each visits: Continuous Performance Test - AX version (CPT-AX), Wisconsin card sorting test( WCST), Working memory test (N-BACK).

Conditions

Interventions

TypeNameDescription
OTHEROwn Brand cigaretteSmoke, 15 puff of, Own Brand cigarettes;
OTHERone high 2,4% nicotineSmoke, 25 puff, of electronic cigarette one high 2,4% nicotine
OTHERoriginal 7,4 mg nicotineSmoke, 15 puff, of Categoria electronic cigarette 7,4 mg nicotine
OTHERnicotine freesmoke, 15 puff, of electronic cigarette nicotine free
OTHEREgo 9mgsmoke, 15 puff, of electronic cigarette Ego 9 mg

Timeline

Start date
2012-09-01
Primary completion
2012-11-01
Completion
2012-12-01
First posted
2012-11-28
Last updated
2012-12-18

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT01735487. Inclusion in this directory is not an endorsement.